Plasma Ceramide Concentrations in Full-Term Pregnancies Complicated with Gestational Diabetes Mellitus: A Case-Control Study.
ceramides
gestational diabetes mellitus
pregnancy
prognostic factors
Journal
Metabolites
ISSN: 2218-1989
Titre abrégé: Metabolites
Pays: Switzerland
ID NLM: 101578790
Informations de publication
Date de publication:
16 Nov 2022
16 Nov 2022
Historique:
received:
06
10
2022
revised:
08
11
2022
accepted:
12
11
2022
entrez:
24
11
2022
pubmed:
25
11
2022
medline:
25
11
2022
Statut:
epublish
Résumé
Ceramides, a sphingolipid group that acts as a messenger in cellular differentiation, proliferation, apoptosis and senescence, have been associated with cardiovascular disease and type 2 diabetes. The evidence for an association between ceramides and gestational diabetes mellitus (GDM) is scarce. This case-control study aimed to compare women with GDM with healthy, pregnant women in terms of plasma ceramide concentrations at the time of delivery. Ninety-two pregnant women were included in this case-control study, 29 in the GDM group and 63 in the control group. All women were admitted to a tertiary academic hospital for a full-term delivery. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) was applied for the quantification of four molecular ceramides, namely Cer d18:1/16:0 (Cer16:0), Cer d18:1/18:0 (Cer18:0), Cer d18:1/24:0 (Cer24:0) and Cer d18:1/24:1 (Cer24:1) in plasma samples. The raw chromatographic data obtained from the LC-MS/MS analysis were processed using Analyst SCIEX (AB Sciex Pte. Ltd., USA). In a univariate statistical analysis, Cer24:0 concentration was significantly lower in the GDM group compared with the control group (
Identifiants
pubmed: 36422262
pii: metabo12111123
doi: 10.3390/metabo12111123
pmc: PMC9698071
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Endocr Dev. 2016;31:163-78
pubmed: 26824237
Obesity (Silver Spring). 2012 Dec;20(12):2341-7
pubmed: 22677645
Pregnancy Hypertens. 2020 Jan;19:100-105
pubmed: 31927322
Lipids. 2020 Jul;55(4):375-386
pubmed: 32430917
Diabetes Res Clin Pract. 2022 Jan;183:109050
pubmed: 34883186
Adv Exp Med Biol. 2019;1161:193-217
pubmed: 31562631
Diabetes Care. 2010 Mar;33(3):676-82
pubmed: 20190296
PLoS One. 2017 Apr 6;12(4):e0175118
pubmed: 28384202
Diabetes. 2009 Feb;58(2):337-43
pubmed: 19008343
Reprod Biol Endocrinol. 2019 Oct 23;17(1):81
pubmed: 31647034
Diabetes Res Clin Pract. 2021 Jan;171:108606
pubmed: 33310119
J Clin Med. 2022 Jan 13;11(2):
pubmed: 35054078
Prostaglandins Other Lipid Mediat. 2016 Mar;123:40-5
pubmed: 27184754
Exp Mol Pathol. 2007 Jun;82(3):298-309
pubmed: 17045585
Hum Reprod Update. 2020 Jun 18;26(4):514-544
pubmed: 32441298
Metabolomics. 2020 Jan 24;16(2):19
pubmed: 31974687
Int J Mol Sci. 2020 Feb 04;21(3):
pubmed: 32033121
Horm Metab Res. 2002 Aug;34(8):466-8
pubmed: 12198604
J Chromatogr B Analyt Technol Biomed Life Sci. 2021 Jun 15;1175:122734
pubmed: 33991953
Curr Diab Rep. 2012 Feb;12(1):33-42
pubmed: 22139557
Metabolites. 2021 Oct 21;11(11):
pubmed: 34822377
Autophagy. 2015 Apr 3;11(4):653-69
pubmed: 25853898
Int J Mol Sci. 2018 Oct 26;19(11):
pubmed: 30373146
J Nutr. 2020 May 1;150(5):1214-1222
pubmed: 31665380
Clin Med (Lond). 2014 Dec;14(6):677-80
pubmed: 25468858
PLoS One. 2015 May 22;10(5):e0127732
pubmed: 26000716
Am J Clin Nutr. 2021 Nov 8;114(5):1763-1773
pubmed: 34477820
Cell Rep. 2017 Feb 28;18(9):2269-2279
pubmed: 28249170
J Clin Lipidol. 2020 Mar - Apr;14(2):176-185
pubmed: 32067904
Diabetes. 2018 Aug;67(8):1663-1672
pubmed: 29588286
Diabetologia. 2018 Dec;61(12):2570-2579
pubmed: 30159588
Mol Metab. 2019 Mar;21:36-50
pubmed: 30655217
Int J Mol Sci. 2018 Dec 11;19(12):
pubmed: 30545025
Int J Mol Sci. 2022 Feb 28;23(5):
pubmed: 35269861